Research Article

You have full text access to this OnlineOpen article

A Dose-Finding Study of Zoledronate in Hypercalcemic Cancer Patients

  1. J. J. Body1,*,
  2. A. Lortholary2,
  3. G. Romieu3,
  4. A. M. Vigneron4,
  5. J. Ford4

Article first published online: 1 SEP 1999

DOI: 10.1359/jbmr.1999.14.9.1557

Issue

Journal of Bone and Mineral Research

Journal of Bone and Mineral Research

Volume 14, Issue 9, pages 1557–1561, September 1999

Additional Information

How to Cite

Body, J. J., Lortholary, A., Romieu, G., Vigneron, A. M. and Ford, J. (1999), A Dose-Finding Study of Zoledronate in Hypercalcemic Cancer Patients. J Bone Miner Res, 14: 1557–1561. doi: 10.1359/jbmr.1999.14.9.1557

Author Information

  1. 1

    Supportive Care Clinic & Bone Diseases Clinic, Institut J. Bordet, Université Libre de Bruxelles, Brussels, Belgium

  2. 2

    Centre Paul Papin, Angers, France

  3. 3

    Centre Val d'Aurelle, Montpellier, France

  4. 4

    Novartis, Rueil-Malmaison, France and Basle, Switzerland

*Address reprint requests to: J.J. Body, M.D., Ph.D., Institut Jules Bordet, Rue Héger-Bordet 1, 1000 Brussels, Belgium

Publication History

  1. Issue published online: 2 DEC 2009
  2. Article first published online: 1 SEP 1999
  3. Manuscript Accepted: 6 APR 1999
  4. Manuscript Revised: 19 MAR 1999
  5. Manuscript Received: 11 NOV 1998

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (193K)

REFERENCES

  • 1
    Fleisch H 1997 Bisphosphonates in Bone Disease—From the Laboratory to the Patient, 3rd Ed. The Parthenon Publishing Group, London, U.K.
  • 2
    Body JJ, Bartl R, Burckhardt P, Delmas PD, Diel IJ, Fleisch H, Kanis JA, Kyle RA, Mundy GR, Paterson AHG, Rubens RD, for the International Bone and Cancer Study Group 1998 Current use of bisphosphonates in oncology J Clin Oncol 16:3890–3899.
  • 3
    Hortobagyi GN, Theriault RL, Lipton A, Porter L, Blayney D, Sinoff C, Wheeler H, Simeone JF, Seaman JJ, Knight RD, Heffernan M, Mellars K, Reitsma DJ, for the Protocol 19 Aredia Breast Cancer Study Group 1998 Long-term prevention of skeletal complications of metastatic breast cancer with pamidronate J Clin Oncol 16:2038–2044.
  • 4
    Berenson JR, Lichtenstein A, Porter L, Dimopoulous A, Bordoni R, George S, Lipton A, Keller A, Ballester O, Kovacs M, Blacklock H, Bell R, Simeone JF, Reitsma DJ, Heffernan M, Seaman J, Knight RD, for the Myeloma Aredia Study Group 1998 Long-term pamidronate treatment of advanced multiple myeloma patients reduces skeletal events J Clin Oncol 16:593–602.
  • 5
    McCloskey EV, MacLennan ICM, Drayson M, Chapman C, Dunn J, Kanis JA 1998 A randomized trial of the effect of clodronate on skeletal morbidity in multiple myeloma Br J Hematol 100:317–325.
  • 6
    Green JR, Müller K, Jaeggi KA 1994 Preclinical pharmacology of CGP 42′446, a new, potent, heterocyclic bisphosphonate compound J Bone Miner Res 9:745–750.
  • 7
    Ralston SH, Thiébaud D, Herrmann Z, Steinhauer EU, Thürlimann B, Walls J, Lichinitser MR, Rizzoli R, Hagberg H, Huss HJ, Tubiana-Hulin M, Body JJ 1997 Dose–response study of ibandronate in treatment of cancer-associated hypercalcaemia Br J Cancer 75:295–300.
  • 8
    Purohit OP, Radstone CR, Anthony C, Kanis JA, Coleman RE 1995 A randomised double-blind comparison of intravenous pamidronate and clodronate in the hypercalcaemia of malignancy Br J Cancer 72:1289–1293.
  • 9
    Body JJ, Dumon JC 1994 Treatment of tumor-induced hypercalcaemia with the bisphosphonate pamidronate: Dose–response relationship and influence of the tumour type Ann Oncol 5:359–363.
  • 10
    Berenson JR, Lipton A, Rosen LS 1996 Phase I clinical study of a new bisphosphonate, zoledronate (CGP-42446), in patients with osteolytic bone metastases Blood 88(Suppl 1):586a.
  • 11
    Body JJ 1997 Clinical research update: Zoledronate Cancer 80:1699–1701.
  • 12
    Paterson AHG, Powles TJ, Kanis JA, McCloskey E, Hanson J, Ashley S 1993 Double-blind controlled trial of oral clodronate in patients with bone metastases from breast cancer J Clin Oncol 11:59–65.
  • 13
    Diel IJ, Solomayer EF, Costa SD, Gollan C, Goerner R, Wallwiener D, Kaufmann M, Bastert G 1998 Reduction in new metastases in breast cancer with adjuvant clodronate treatment N Engl J Med 339:357–363.
View Full Article (HTML) Get PDF (193K)